Pacira BioSciences (PCRX) faces Exparel generic threats in 2024. Learn about risks, portfolio strategy shifts, and key ...
The fourth plenary session of the 20th CPC Central Committee marks an important moment in China's current political life. By ...
The cell will focus on policy formulation, strategy development, and ethical implementation of AI-based systems within the ...
Lantheus Holdings, Inc. ( LNTH) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST ...
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced robust preliminary ...
Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...
Race Oncology, EZZ Life Science and Neurotech International are among ASX health companies reporting quarterly results.
Ligand is increasing its 2025 full year financial guidance. The Company now expects total core revenue of $225 million to ...
Galaxi Brands today announced the upcoming launch of its revolutionary creator-led marketplace, a full-service platform ...
Revenue Mix -- Approximately 55% of Q3 2025 revenue came from services (automotive OEMs, AI-enhanced battery material ...
The launch marks the first anniversary of GMG’s Home division and reflects the company’s focus on the UAE’s growing design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback